Evolent Health Stock Investor Sentiment

EVH Stock  USD 12.92  0.01  0.08%   
Under 57% of Evolent Health's investor base is looking to short. The analysis of the overall investor sentiment regarding Evolent Health suggests that many traders are alarmed. Evolent Health's investing sentiment shows overall attitude of investors towards Evolent Health.
  

Evolent Health Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Evolent Health can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
over six months ago at investing.com         
Evolent Health stock target cut by Canaccord, retains buy rating
Investing News at Macroaxis
over six months ago at news.google.com         
Legato Capital Management LLC Decreases Stake in Evolent Health, Inc. - Defense World
Google News at Macroaxis
over six months ago at news.google.com         
American Century Companies Inc. Lowers Position in Evolent Health, Inc. - MarketBeat
Google News at Macroaxis
over six months ago at news.google.com         
Wellington Management Group LLP Raises Holdings in Evolent Health, Inc. - MarketBeat
Google News at Macroaxis
over six months ago at zacks.com         
Does Evolent Health Have the Potential to Rally 34.46 percent as Wall Street Analysts Expect?
zacks News
over six months ago at finance.yahoo.com         
Does Evolent Health Have the Potential to Rally 34.46 percent as Wall Street Analysts Expect?
Yahoo News
over six months ago at simplywall.st         
Evolent Health Is Experiencing Growth In Returns On Capital
Simply Wall St News at Macroaxis
over six months ago at thelincolnianonline.com         
Evolent Health, Inc. Receives 41.38 Consensus Price Target from Brokerages
news
over six months ago at finance.yahoo.com         
Getinge takes a leap forward in cardiovascular surgery with the 510 clearance for Vasoview Hemopro 3
Yahoo News
over six months ago at thelincolnianonline.com         
Evolent Health Earns Outperform Rating from Analysts at Oppenheimer
news
over six months ago at thelincolnianonline.com         
Disposition of 7460 shares by Jonathan Weinberg of Evolent Health at 34.41 subject to Rule 16b-3
news
over six months ago at www.macroaxis.com         
Disposition of 5638 shares by Dan McCarthy of Evolent Health at 34.41 subject to Rule 16b-3
Macroaxis News
over six months ago at news.google.com         
Disposition of 13210 shares by Dan McCarthy of Evolent Health at 34.41 subject to Rule 16b-3
Google News at Macroaxis
over six months ago at gurufocus.com         
Q4 2023 Evolent Health Inc Earnings Call Transcript
Gurufocus Stories at Macroaxis
over six months ago at zacks.com         
Wall Street Analysts Predict a 35.7 percent Upside in Evolent Health Heres What You Should Know
zacks News
Far too much social signal, news, headlines, and media speculation about Evolent Health that are available to investors today. That information is available publicly through Evolent media outlets and privately through word of mouth or via Evolent internal channels. However, regardless of the origin, that massive amount of Evolent data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Evolent Health news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Evolent Health relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Evolent Health's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Evolent Health alpha.

Evolent Health Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Disposition of 2569 shares by Aammaad Shams of Evolent Health at 34.41 subject to Rule 16b-3
09/06/2024
2
Evolent Health Inc Stock Price Down 3.83 percent on Sep 23
09/23/2024
3
Evolent Health Reports Next Week What to Know Ahead of the Release
10/31/2024
4
Evolent Health Non-GAAP EPS of 0.04 misses by 0.30, revenue of 621.4M misses by 5.75M
11/07/2024
5
Evolent Health Inc Q3 2024 Earnings Call Highlights Navigating Medical Cost Challenges ...
11/08/2024
6
Evolent Health Stock Price Down 3.8 percent Following Analyst Downgrade
11/13/2024
7
Evolent Healths SWOT analysis stock faces headwinds amid growth potential
11/14/2024
8
Granahan Investment Management Reduces Stake in Castle Biosciences Inc
11/15/2024
9
Evolent Health Inc Stock Price Down 4.77 percent on Nov 20
11/20/2024
10
Evolent Health Inc Stock Price Up 4.26 percent on Nov 26
11/26/2024

Complementary Tools for Evolent Stock analysis

When running Evolent Health's price analysis, check to measure Evolent Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Evolent Health is operating at the current time. Most of Evolent Health's value examination focuses on studying past and present price action to predict the probability of Evolent Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Evolent Health's price. Additionally, you may evaluate how the addition of Evolent Health to your portfolios can decrease your overall portfolio volatility.
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Transaction History
View history of all your transactions and understand their impact on performance